
School of Pharmacy instructor calls for more equity in ‘Test to Treat’
A Loma Linda University School of Pharmacy instructor is calling for the national “Test to Treat” initiative to include pharmacists as designated providers who can both diagnose and treat COVID-19 patients in one location under Emergency Use Authorization — a move, she says, would help mitigate minority barriers to care.
Assistant Professor Jacinda Abdul-Mutakabbir, PharmD, MPH, published her appeal today as a commentary in The Lancet Regional Health – Americas, co-authored by other supportive pharmacists and physicians across the nation who first saw her comments in a social media post.